Already active in several U.S. regions, AmeXio has earned a strong reputation over the past 15 years through its work with leading pharmaceutical and MedTech companies in North America and Europe. With rising regulatory scrutiny and compressed product timelines,

AmeXio is now scaling its U.S. operations under the leadership of Dan Schneider, Managing Director for North America.
“We’ve been successfully partnering with U.S.-based MedTech clients, and now we’re expanding that footprint to meet broader demand,” said Schneider. “Structured content is a natural fit for this industry’s fast-paced, compliance-heavy environment—making it a renewed strategic focus for us.”

AmeXio’s SCM approach utilizes XML DITA and other XML standards, supported by Component Content Management Systems (CCMS), to deliver modular, reusable content frameworks. These models enhance content traceability, streamline regulatory submissions, and eliminate redundant authoring—all while improving audit readiness across geographies. For medical device manufacturers navigating multilingual labeling, shifting regulations, and rapid product cycles, SCM offers measurable gains in efficiency and accuracy.

What It Means for Customers

For current and prospective clients, AmeXio’s expanded U.S. presence translates into faster access to expert consulting, localized support, and scalable solutions tailored to regulatory content challenges. By adopting SCM, organizations can:
· Reuse approved content across multiple products, geographies, and media.
· Cut documentation timelines by up to 50%.
· Avoid inconsistencies that trigger audit flags or delay approvals.
· Accelerate translation and localization using structured, metadata-rich assets.
· Improve precision and consistency in AI/LLM outputs through uniform content models

These benefits significantly reduce manual workloads, improve cross-departmental alignment, and provide a foundation for long-term digital transformation. Whether supporting FDA compliance, launching new product lines, or harmonizing digital and print outputs, AmeXio’s methodology empowers teams to deliver content at the speed of business.

While the medical device industry is the company’s initial priority in this phase, AmeXio also supports adjacent sectors including biopharmaceuticals, diagnostics, and digital health technologies.